Asthma Medication Denied: Survey Reveals Parents Struggling to Afford Vital Child Health Treatments

A new survey has revealed a stark and growing crisis in Ireland, where one in ten children with asthma have been forced to go without their vital medication in the past three months because their parents cannot afford it. The findings, released ahead of World Asthma Day 2026, underscore a broader affordability challenge that is leaving children at serious risk of severe asthma attacks and hospitalization.

The survey, conducted by the Asthma Society of Ireland, found that over a third of children with asthma have been hospitalized due to their condition in the past year, with one in seven requiring multiple admissions. The financial strain on families is clear: over half of respondents reported struggling to make ends meet, and nearly a quarter of all asthma patients—including children—have skipped medication because of cost.

While the survey does not directly name any celebrities or public figures as advocates, it aligns with the ongoing efforts of health correspondents like Eilish O’Regan, who has long covered critical healthcare issues in Ireland. O’Regan’s reporting has highlighted the urgent need for accessible healthcare, particularly for vulnerable populations such as children with chronic conditions.

Why This Matters for Families and Public Health

The inability to access necessary medication is not just a financial issue; it is a public health crisis. Asthma is a chronic condition that, if left unmanaged, can lead to life-threatening situations. The survey results come as a call to action for policymakers to address the affordability of asthma treatment, particularly for low-income families. The Asthma Society of Ireland has previously called for the phased subsidization of maintenance and reliever therapy (MART) combination inhalers, a measure that could significantly reduce the burden on families.

World Asthma Day serves as a reminder of the global impact of asthma and the importance of raising awareness. In Ireland, the day also highlights the need for systemic change to ensure that no child or family is left without the medication they need to breathe safely.

Advocacy and Public Awareness

Public figures and organizations have increasingly drawn attention to the challenges faced by families with chronic illnesses. While the survey itself does not reference specific celebrity involvement, the broader context of health advocacy in Ireland—including efforts by journalists, healthcare professionals, and patient advocacy groups—has been instrumental in pushing for policy changes.

For instance, the Jack and Jill Children’s Foundation and other charitable organizations have launched initiatives to support children’s health, including art sales and fundraising events. These efforts, while not directly tied to asthma medication access, reflect a growing public consciousness about the needs of children with chronic conditions.

Looking Ahead: Policy and Community Support

The Asthma Society of Ireland’s pre-Budget 2026 submission emphasized the need for urgent action to make gold-standard asthma treatment more affordable. The society’s proposals include the subsidization of MART inhalers and other critical medications, which could prevent unnecessary hospitalizations and improve outcomes for children and adults alike.

As Ireland prepares for Budget 2026, the survey results serve as a stark reminder of the human cost of inaction. Families, healthcare providers, and advocacy groups are united in calling for meaningful change to ensure that every child with asthma can access the treatment they need without financial hardship.

The message is clear: no parent should have to choose between affording medication and other essentials. The time for action is now, and the health and well-being of Ireland’s children depend on it.